Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Harm Reduction topic

No spam. Unsubscribe anytime.

Senate approves framework to expand harm-reduction services and decriminalize paraphernalia after heated debate

Delaware Senate ยท May 14, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

After hours of floor debate and expert testimony, the Delaware Senate passed Senate Bill 249 (with Amendment 2), creating a statewide regulatory framework for harm-reduction programs, decriminalizing possession of paraphernalia for personal use and authorizing DSAMH to contract with providers; the final roll call recorded 15 yes, 6 no.

Senate Bill 249, a bill to amend state law governing harm-reduction programs and paraphernalia, cleared the Delaware Senate on May 14 after extended debate and the incorporation of Senate Amendment 2.

Sponsor Senator D. Pinkney described the measure as a public-health proposal aimed at reducing overdose deaths and disease transmission by establishing a regulatory framework for evidence-based harm-reduction services. "What the bill does is recognize the difference between large-scale criminal conduct and individuals struggling with addiction who possess a syringe, a straw, or testing strip," Pinkney said, urging support for a strategy focused on keeping people alive and creating pathways to treatment.

The bill explicitly allows DSAMH (the Division of Substance Abuse and Mental Health) to regulate and contract with service providers that can offer services such as sterile supplies, infectious-disease screening, wound care, naloxone distribution and referral to behavioral-health care and social supports. Proponents emphasized that the bill preserves criminal penalties for trafficking and manufacturing controlled substances.

Opponents raised concerns about the scope of supplies covered and community impacts. Senator Buxton warned that the legislation could "legalize the distribution of drug paraphernalia" by authorizing state-funded programs to provide sterile supplies and related items, and argued it risks proliferating visible paraphernalia in public spaces. Senator Lawson questioned whether decriminalizing paraphernalia would reduce law-enforcement leverage to refer people into treatment.

Joe Aronson, chief of government relations at DSAMH, joined remotely to answer technical questions. He said the bill creates a framework rather than specifying a fixed supply list and that regulatory and contractual processes would determine the specific supplies and service standards. "The bill doesn't require them [providers] to provide a specific supply at any time," Aronson said, adding that DSAMH envisions a regulatory process to set details and that current programs use mixed funding sources.

Debate also focused on safeguards and whether the bill replaces the criminal-justice touchpoint used to route some people into diversion or treatment programs. Supporters noted the bill retains arrest authority when controlled substances are present and added an amendment to emphasize continued cooperation with law enforcement and deflection opportunities.

On the final roll call for SB 249, as amended, the Senate recorded 15 yes and 6 no; the chair declared the bill passed to the Senate. The roll call listed individual votes in the record. The next procedural step is for the bill to move toward further consideration consistent with Senate rules and implementation via DSAMH regulations should it become law.